Gufler, J., Heffeter, P., Kowol, C. R., Hager, S., & Marko, D. (2025). Opposing effects of mycotoxins alternariol and deoxynivalenol on the immunomodulatory effects of oxaliplatin and triapine. Toxicology, 511, Article 154039. https://doi.org/10.1016/j.tox.2024.154039

Labuda, R., Bacher, M., Rosenau, T., Gratzl, H., Doppler, M., Hager, S., Marko, D., Wiesner, C., Očková, M., Ollinger, N., Wagner, M., Schüller, C., & Strauss, J. (2024). Chemical composition of anti-microbially active fractions derived from extract of filamentous fungus Keratinophyton Lemmensii including three novel bioactive compounds. Scientific Reports, 14(1), Article 25310. https://doi.org/10.1038/s41598-024-75510-1

Louro, H., Vettorazzi, A., López de Cerain, A., Spyropoulou, A., Solhaug, A., Straumfors, A., Behr, A. C., Mertens, B., Žegura, B., Fæste, C. K., Ndiaye, D., Spilioti, E., Varga, E., Dubreil, E., Borsos, E., Crudo, F., Eriksen, G. S., Snapkow, I., Henri, J., ... Marko, D. (2024). Correction to: Hazard characterization of Alternaria toxins to identify data gaps and improve risk assessment for human health (Archives of Toxicology, (2024), 98, 2, (425-469), 10.1007/s00204-023-03636-8). Archives of Toxicology, 98(10), 3513-3514. https://doi.org/10.1007/s00204-024-03818-y

Cai, Z., Li, W., Hager, S., Wilson, J. L., Afjehi-Sadat, L., Heiss, E. H., Weichhart, T., Heffeter, P., & Weckwerth, W. (2024). Targeting PHGDH reverses the immunosuppressive phenotype of tumor-associated macrophages through α-ketoglutarate and mTORC1 signaling. Cellular and Molecular Immunology, 21(5), 448-465. https://doi.org/10.1038/s41423-024-01134-0

Louro, H., Vettorazzi, A., López de Cerain, A., Spyropoulou, A., Solhaug, A., Straumfors, A., Behr, A. C., Mertens, B., Žegura, B., Fæste, C. K., Ndiaye, D., Spilioti, E., Varga, E., Dubreil, E., Borsos, E., Crudo, F., Eriksen, G. S., Snapkow, I., Henri, J., ... Marko, D. (2024). Hazard characterization of Alternaria toxins to identify data gaps and improve risk assessment for human health. Archives of Toxicology, 98(2), 425-469. https://doi.org/10.1007/s00204-023-03636-8

Gufler, J., Marko, D., Heffeter, P., & Hager, S. (2024). Opposite effects of food mycotoxins altemariol and deoxynivalenol on the immunomodulatory properties of anticancer drug oxaliplatin. Naunyn-Schmiedeberg's Archives of Pharmacology, 397(Suppl.1), S75-S76. Article P244.

Schaier, M., Falcone, E., Prstek, T., Vileno, B., Hager, S., Keppler, B. K., Heffeter, P., Koellensperger, G., Faller, P., & Kowol, C. R. (2023). Human serum albumin as a copper source for anticancer thiosemicarbazones. Metallomics, 15(8), Article mfad046. https://doi.org/10.1093/mtomcs/mfad046

Strasser, P., Montsch, B., Weiss, S., Sami, H., Kugler, C., Hager, S., Schueffl, H., Mader, R., Brüggemann, O., Kowol, C. R., Ogris, M., Heffeter, P., & Teasdale, I. (2023). Degradable Bottlebrush Polypeptides and the Impact of their Architecture on Cell Uptake, Pharmacokinetics, and Biodistribution In Vivo. Small, 19(22), Article 2300767. https://doi.org/10.1002/smll.202300767